ALTHX — Theranexus SA Income Statement
0.000.00%
Last trade - 00:00- €7.67m
- €9.57m
Annual income statement for Theranexus SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | FAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.1 | 9.51 | 7.03 | 7.64 | 2.53 |
| Operating Profit | -6.1 | -9.51 | -7.03 | -7.64 | -2.53 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.79 | -9.91 | -7.19 | -7.63 | -2.53 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.8 | -8.15 | -6.57 | -6.83 | -1.77 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.8 | -8.15 | -6.57 | -6.83 | -1.77 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.8 | -8.15 | -6.57 | -6.83 | -1.77 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.17 | -1.62 | -1.13 | -0.88 | -0.236 |
| Dividends per Share |